Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2026-02-23 @ 8:31 PM
Study NCT ID:
NCT06446804
Status:
COMPLETED
Last Update Posted:
2024-11-01
First Post:
2024-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Follow-up of Migraine Patients on Eptinezumab
Sponsor:
Centre Hospitalier Universitaire de Nīmes
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LOCAL/2024/AL-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None